AREV Incorporates in Cambodia and Enters into JV


VANCOUVER, BC – TheNewswire - December 3, 2020 - AREV NANOTEC BRANDS INC. (CSE:AREV) (CNSX:AREV.CN) (OTC:AREVF) (“AREV Nanotec”) announces that it has completed the incorporation of its Cambodia Corporation. The Cambodian company, AREV Brands Cambodia Inc. has been established to import and distribute extracts, ingredients and finished pharma and nutraceutical products throughout the South East Asian market. AREV Nanotec owns 51% of the company in partnership with Furi Corporation (49%), one of the largest real estate developers in Cambodia.


Mr. Michael Nen, has agreed to serve as President of Arev Brands Cambodia Inc.  Mr. Nen has recently been working with AREV Nanotec as South East Asia regional director. He has served in law enforcement in the US and was integral in obtaining the only Gambling License to be issued to Naga World Casino in Phnom Penh.  Mr. Nen is actively working with the Ministries of Economic Development and Health in Cambodia to obtain the necessary import licenses for AREV Nanotec to export its nutraceutical and pharmaceutical products to Cambodia.


The population of Cambodia is 16.3 million and its annual economic growth rate is 7.1%.  Strong regional trade activity exists with the immediate neighbouring countries of Vietnam, Laos, Thailand, Malaysia and China. The potential market size for the SE Asia region is 671,379,444 and represents 8.5% of the world’s population according to Worldometer.


According to the Nutrition Business Journal, its most recent strategic market reports the immune supplement market is expected to grow more than 25% by 2021, due in no small part to concerns surrounding COVID-19 (for context, in 2019, the category grew 8.5%), and the resulting enhanced consumer interest in numerous new immune health products.  


Arev Nanotec ingredients make medicines better and are an excellent offering for these shoppers, capable of providing seasonal support or everyday maintenance, thanks to their double-acting positive effects on the body’s immunity. They also reduce stress and improve sleep to enhance productivity  


The head office of Arev Nanotec Brands Inc. is located in Coquitlam, British Columbia, Canada.  Since the Company moved into its new premises in January 2020, it has enhanced its laboratory and extraction facilities to occupy 5,000 square feet.  The building contains an array of modern tools and its proprietary extraction equipment, capable of producing large quantities of natural extract substances with a significant level of consistency at the molecular level.  The extraction equipment can obtain extracted products in several different methods utilizing pressure, water, alcohols, heat, centrifugal energy and ultrasound. Arev is able to produce a broad range of extracts and substance blends from many natural substances.  The list includes but is not limited to Sea Cucumber oil, Hops extract, Hemp oil and related CBD extracts, several distinct mushroom extractions, ginseng “Ginse” (Health Canada NPN 80015898), curcumin, Kampot pepper extracts, frankincense and moringa.


Extracts derived from these natural substances are noted to have positive healthful effects on human conditions ranging from immune enhancement, muscular and tissue inflammation, memory enhancement, bodily energetic needs and numerous other metabolic functions.  The natural substances utilized are numerous and the resulting extractions are broad in scope and application for use in nutraceuticals and pharmaceuticals.


In the previous fiscal year, the company expended significant cash resources towards the development of its research and development projects and product formulations to enable the completion of the enhanced extraction skills and knowledge that have occurred as a result of the integration of the new machines into the company’s proprietary extraction technologies.


For further information, contact Mike Withrow, 778-929-6536.


On behalf of the Board,


Mike Withrow
CEO & Director

About AREV NanoTec Inc.  
AREV NanoTec Brands Inc. (“AREV”) produces and sells functional ingredients produced via its proprietary extraction systems. These premium ingredients and products are targeted for the natural health, medical, functional food, nutraceutical, sport nutrition markets. AREV’s model is to toll process extraction of targeted essential and functional oils and license its formulations to Licensed Producers in Canada.  The company utilizes toll processors in foreign countries to encapsulate and package its formulations that can be sold in traditional distribution channels and online.





Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws. This press release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements.  Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks various risk factors discussed in the Company’s Management’s Discussion and Analysis under the Company’s profile on   

Copyright (c) 2020 TheNewswire - All rights reserved.

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.